What GLP-1s actually do to your gut

GLP-1 receptor agonists, the class that includes semaglutide and related medications, are now widely prescribed. They are usually discussed as weight or blood sugar medications. Mechanically, though, they are gut medications, and the gut is where most of their side effects live.

The mechanism, in one paragraph

GLP-1 is a hormone your small intestine already releases after you eat. It signals fullness to the brain, prompts insulin release, and slows gastric emptying, meaning food stays in your stomach longer. The medications mimic that hormone at a much stronger and steadier level than your body produces on its own. The result is that you feel full sooner, stay full longer, and eat less. That is the intended effect, and everything below follows from it.

Why your gut notices

Slowing the stomach changes the timetable for everything downstream. The common effects cluster into a few groups:

• Nausea, the most common complaint, especially in the first weeks and after dose increases. A fuller stomach for longer is exactly the condition nausea likes.
• Constipation, because slower transit gives the colon more time to pull water out. On the Bristol scale this shows up as a drift toward types 1 and 2.
• Diarrhoea, which sounds contradictory but is common too. The system is adjusting to a new rhythm, and some guts overcorrect.
• Reflux and burping, again from food sitting in the stomach longer than it used to.

For most people these effects are strongest early, strongest around dose changes, and settle as the body adapts. Severe or persistent symptoms, especially intense abdominal pain or repeated vomiting, are a reason to call your prescriber rather than push through.

What helps, practically

• Smaller meals, eaten more slowly. The stomach has less room on this timetable.
• Fibre and fluids, the standard constipation counterweights.
• Going easy on heavy, fatty meals, which empty slowest of all.
• Telling your prescriber what's happening. Dose pacing exists for exactly this reason, and they can only pace what they know about.

The tracking angle

GLP-1 side effects follow patterns: injection day versus the days after, one dose level versus the next, week one versus week six. A daily record makes those patterns easier to see. A note in your check-in on dose days turns the conversation with your prescriber from “I've felt a bit rough” into “the nausea was worst the two days after each dose, then eased”. The second sentence is more useful to them.